TrialBlood2013

Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers.

Cedric Ghevaert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.